Joachim Christ to lead corporate controlling at Merck KGaA
pharmafile | November 15, 2011 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Merck KGaA
Joachim Christ will join Merck KGaA on 1 January next year as its new head of corporate controlling.
Christ, 46, completed an apprenticeship as an industrial management specialist and earned a degree in business administration while working for Hoechst.
Starting in 1987, he held a variety of management positions of increasing responsibility, initially within controlling at Hoechst and later on at its successor company, Aventis.
During the course of his career he has held the positions of controller for a strategic business unit and regional controller for Europe/Middle East/Africa, as well as controller for global production.
In 2004 Christ took over the leadership of corporate controlling at Lanxess in Leverkusen in Germany to build this function in the newly created company, from where he will now be moving to Merck.
He will report to Matthias Zachert, the firm’s chief financial officer, who said: “Because of his past positions at Hoechst, Aventis and Lanxess, Joachim Christ has extensive experience in both the pharmaceutical and chemical industries as well as in the controlling function.”
Related Content

Exscientia enters AI drug discovery collaboration with Merck KGaA
Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on …

Merck KGaA’s cancer drug Bavencio gets EU approval
The EC has approved Merck KGaA’s BAVENCIO (avelumab) as monotherapy for the first-line maintenance treatment …

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO
German pharma firm Merck KGaA has taken the decision to appoint its first female Chief …






